Arrowstreet Capital
AXGN icon

Arrowstreet Capital’s Axogen AXGN Stock Holding History

Arrowstreet Capital’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5M Buy
443,025
+183,728
+71% +$7.41M 0.01% 850
2026
Q1 		$8.59M Sell
259,297
-450,474
-63% -$14.6M ﹤0.01% 993
2025
Q4 		$23.2M Buy
709,771
+220,942
+45% +$5.43M 0.01% 697
2025
Q3 		$8.72M Buy
488,829
+459,707
+1,579% +$6.67M 0.01% 998
2025
Q2 		$316K Sell
29,122
-68,168
-70% -$893K ﹤0.01% 1828
2025
Q1 		$1.8M Hold
97,290
– – ﹤0.01% 1326
2024
Q4 		$1.6M Buy
97,290
+26,298
+37% +$372K ﹤0.01% 1335
2024
Q3 		$995K Buy
+70,992
New +$785K ﹤0.01% 1389
2024
Q2 		– Sell
-17,522
Closed -$141K – 1526
2024
Q1 		$141K Sell
17,522
-35,571
-67% -$319K ﹤0.01% 1599
2023
Q4 		$363K Buy
+53,093
New +$295K ﹤0.01% 1266
2016
Q4 		– Sell
-59,351
Closed -$535K – 1657
2016
Q3 		$535K Buy
+59,351
New +$483K ﹤0.01% 1232

Other funds holding AXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Arrowstreet Capital's AXGN Position: Q2 2026 in Review

Arrowstreet Capital increased its Axogen (AXGN) stake by 71% in Q2 2026, buying an estimated $7.41M and bringing the position to 443,025 shares worth $20.5M. The position accounts for 0.01% of the portfolio, ranked #850.

Arrowstreet Capital first reported a position in AXGN in Q3 2016 and has held it in 11 quarters since. The position peaked at $23.2M in Q4 2025. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Arrowstreet Capital held 443,025 shares of Axogen worth $20.5M as of Q2 2026.
  • Arrowstreet Capital bought 183,728 Axogen shares in Q2 2026, an estimated $7.41M.
  • Axogen made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #850 holding.
  • Arrowstreet Capital first reported a position in Axogen in Q3 2016 and has held it in 11 quarters since.
  • Arrowstreet Capital's Axogen position peaked at $23.2M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.